Bytes: Week in Review — OpenAI’s valuation doubles, biotech investment grows and a prescription giant is acquired

Investors are once again pouring money into biotechnology startups. But this time, it feels different from the heyday of 2021. We’ll be digging into the latest data for today’s Marketplace “Tech Bytes: Week in Review,” our roundup of the week’s top headlines, including some you might have missed. We’ll also talk about a private equity deal with the country’s biggest digital pharmacy platform. But first, OpenAI closes a historic funding round. The maker of ChatGPT raised another $6.6 billion — valuing the company at $157 billion, double its worth earlier this year. Our regular contributor Christina Farr, managing director with Manatt Health, joins Marketplace’s Meghan McCarty Carino to discuss the news.